Qiagen N.V.

NYSE:QGEN

Medical - Diagnostics & Research

Healthcare
$49.56 -0.96%

-$0.35 today

Market cap
$10.23B
Beta
0.66
P/E (TTM)
18.6
EPS (TTM)
$1.94
Dividend yield
0.69%
52W Low $32.53High $57.82

Volume 4.26M

Average 2.07M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$654.33M

FY 2025 · Annual

-2.9% YoY

Investing Cash Flow

-$305.28M

FY 2025 · Annual

Financing Cash Flow

-$178.98M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income512.6M423.21M341.3M83.59M424.88M
Depreciation & Amortization214.93M208.4M205.34M203.27M193.75M
Deferred Income Tax(5.29M)(9.6M)10.73M(23.04M)(20.07M)
Stock-Based Compensation38.39M49.51M47.1M43.63M50.4M
Change in Working Capital(130.01M)(31.88M)(186.96M)135.45M(34.51M)
Accounts Receivables(7.4M)15.45M(55.12M)12.22M(36.39M)
Inventory(81.8M)(61.95M)(44.79M)87.76M(848K)
Accounts Payables(5.98M)(1.76M)(22.42M)1.45M(8.42M)
Other Working Capital(34.83M)16.37M(64.64M)34.03M11.15M
Other Non-Cash Items8.38M75.63M41.94M230.65M39.88M
Operating Cash Flow639M715.26M459.46M673.55M654.33M
Capital Expenditures(206.53M)(149.34M)(162.8M)(167.17M)(201.05M)
Acquisitions (Net)(16.63M)(63.65M)(149.53M)0(291.23M)
Purchases of Investments(400.3M)(1.39B)(979.32M)(688.38M)(371.82M)
Sales of Investments359.56M883.08M1.27B584.98M597.06M
Other Investing Activities61.47M(9.77M)(66.55M)21.35M(32.16M)
Investing Cash Flow(202.43M)(726.76M)(87.66M)(249.23M)(305.28M)
Debt Repayment(41.35M)(108.55M)(436.76M)(107.33M)208.15M
Common Stock Issued7.92M0000
Common Stock Repurchased(99.99M)(25.36M)(17.68M)(292.1M)(307.36M)
Dividends Paid0000(54.24M)
Other Financing Activities(16.95M)8.11M20.61M(23.47M)(25.53M)
Financing Cash Flow(150.37M)(125.8M)(433.83M)(422.9M)(178.98M)
Effect of Forex Changes(3.68M)(12.55M)(558K)(5.96M)5.38M
Net Change in Cash282.53M(149.85M)(62.59M)(4.53M)175.45M
Free Cash Flow432.47M565.93M296.65M506.38M453.28M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$424.9M
+ D&A$193.7M
+ Stock-Based Comp$50.4M
- Deferred Tax-$20.1M
- Working Capital-$34.5M
+ Other Non-Cash$39.9M
= Operating Cash Flow$654.3M
- Capex-$201.0M
= Free Cash Flow$453.3M

Analysis

FY2025 free cash flow is $453.3M. FCF conversion is 106.7% of net income. Operating cash flow was $654.3M, with capex of -$201.0M. The largest bridge item is Capex at -$201.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
6-K6-K filingNov 6, 2026
SC TO-CSC TO-C filingOct 28, 2026
6-K6-K filingOct 23, 2026

Does QGEN generate free cash flow?

Qiagen N.V. (QGEN) generated $453.28M of free cash flow in fiscal 2025.

How much operating cash flow does QGEN produce?

Operating cash flow was $654.33M, before capital expenditures of $201.05M.